ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$71.86
+3.07 (+4.46%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+121.11%
YTD
+6.00%
Open$68.85
Previous Close$68.79
Day High$72.37
Day Low$68.08
52W High$95.49
52W Low$29.04
Volume—
Avg Volume2.37M
Market Cap9.29B
P/E Ratio—
EPS$-2.24
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$66.84
Above
SMA 200
$36.65
Above
RSI (14)
36.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-3.3% upside
Current
$71.86
$71.86
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 866.84M | 575.90M | 3.64B |
| Net Income | -1,705,418 | -1,019,715 | -138,687,526 |
| Profit Margin | -0.2% | -0.2% | -3.8% |
| EBITDA | 127.78M | 80.65M | -183,881,108 |
| Free Cash Flow | — | — | -98,110,953 |
| Rev Growth | +50.5% | +50.5% | +9.5% |
| Debt/Equity | 1.34 | 1.34 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |